Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-01-09 @ 8:32 AM
Study NCT ID:
NCT03587805
Status:
COMPLETED
Last Update Posted:
2025-03-11
First Post:
2018-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Sponsor:
LEO Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LP0162-1337
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None